When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MBRX - Moleculin Bio +15% premarket on filing new patent for Covid-19 drug candidate
Moleculin Biotech Inc.
Moleculin Biotech (NASDAQ:MBRX) has filed a new patent application covering the use of WP1122 and its analogs as therapies to limit the ability of coronavirus and other viruses to replicate.
More news on: Moleculin Biotech, Inc., Healthcare stocks news, Stocks on the move,